No. 22A272
Title:Novartis Pharmaceuticals Corporation, Applicant
HEC Pharm Co., Ltd., et al.
Docketed:September 29, 2022
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2021-1070)
   Decision Date:
   Rehearing Denied:
  Discretionary Court Decision Date:

DateProceedings and Orders
Sep 28 2022Application (22A272) for a stay, submitted to The Chief Justice.
Main DocumentLower Court Orders/OpinionsProof of Service
Sep 29 2022Upon consideration of the application of counsel for the applicant, it is ordered that the mandate of the United States Court of Appeals for the Federal Circuit, case No. 2021-1070, is hereby stayed pending further order of The Chief Justice or of the Court. It is further ordered that a response to the application be filed on or before Wednesday, October 5, 2022, by noon (EDT).
Oct 05 2022Response to application from respondent HEC Pharm Co., Ltd., et al. filed.
Main DocumentMain DocumentProof of Service
Oct 07 2022Reply of applicant Novartis Pharmaceuticals Corporation filed.
ReplyProof of Service
Oct 11 2022Supplemental letter from applicant filed.
Main DocumentOther
Oct 11 2022Supplemental letter from respondents filed.
Main Document
Oct 13 2022Application (22A272) referred to the Court.
Oct 13 2022Application (22A272) for stay of the mandate presented to The Chief Justice and by him referred to the Court is denied. The order heretofore entered by The Chief Justice is vacated.

Attorneys for Petitioner
William McGinley Jay
    Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036
Party name: Novartis Pharmaceuticals Corporation
Attorneys for Respondents
Peter K. Stris
    Counsel of Record
Stris and Maher LLP
777 S. Figueroa Street
Suite 3850
Los Angeles, CA 90017
Party name: HEC Pharm Co., Ltd., et al.